Join to View Full Profile
925 N 87th StMilwaukee, WI 53226
Phone+1 414-955-2020
Fax+1 414-955-6300
Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Anthony Jones, DO, is an ophthalmologist based in Milwaukee, WI, specializing in retinal disease. He completed his medical education at Rocky Vista University College of Osteopathic Medicine in 2020, followed by a transitional internship at HCA HealthONE /Sky Ridge Medical Center. He then pursued a residency and fellowship in ophthalmology and surgical retina and vitreous at the Medical College of Wisconsin Affiliated Hospitals, expected to finish in 2026. Dr. Jones has contributed to several publications, including studies on secondary glaucoma, Von Hippel-Lindau disease, and retinal vasculitis.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Surgical Retina and Vitreous, 2024 - 2026- Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 2021 - 2024
HCA HealthONE /Sky Ridge Medical CenterInternship, Transitional Year, 2020 - 2021
Rocky Vista University College of Osteopathic MedicineClass of 2020
Certifications & Licensure
WI State License 2023 - 2025
Publications & Presentations
PubMed
- Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity.Anthony A Jones, Jacob S Martin, Annette L Giangiacomo, Deborah M Costakos
American Journal of Ophthalmology Case Reports. 2024-12-01 - 1 citationsSUCCESSFUL TREATMENT OF VON HIPPEL-LINDAU DISEASE-ASSOCIATED RETINAL CAPILLARY HEMANGIOBLASTOMA WITH BELZUTIFAN IN A PEDIATRIC PATIENT.Anthony A Jones, Nathan J Schloemer, William J Wirostko
Retinal Cases & Brief Reports. 2024-09-01 - Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease.Li Xu, Jessi R Prentice, Raul Velez-Montoya, Alina Sinha, Mark R Barakat
Ophthalmology Science. 2024-01-18
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
